Edition:
United Kingdom

RaySearch Laboratories AB (publ) (RAYb.ST)

RAYb.ST on Stockholm Stock Exchange

98.35SEK
14 Dec 2018
Change (% chg)

-2.75kr (-2.72%)
Prev Close
101.10kr
Open
100.00kr
Day's High
100.00kr
Day's Low
98.35kr
Volume
62,052
Avg. Vol
133,250
52-wk High
173.30kr
52-wk Low
96.60kr

Latest Key Developments (Source: Significant Developments)

Raysearch Q2 EBIT 26.3 mln SEK, order intake up
Thursday, 23 Aug 2018 

Aug 23 (Reuters) - RaySearch Laboratories AB (publ) ::RAYSEARCH Q2 NET SALES SEK 141.0 M.RAYSEARCH Q2 OPERATING PROFIT SEK 26.3 M.RAYSEARCH Q2 ORDER INTAKE EXCLUDING. SERVICE AGREEMENTS SEK 160.3 M.RAYSEARCH SAYS LONG-TERM STRATEGY FEELS SECURE AND IN 2018, WE WILL CONTINUE TO EXPAND OUR GLOBAL MARKETING ORGANIZATION, TO ACCELERATE SALES OF BOTH RAYSTATION AND RAYCARE.RAYSEARCH SAYS THIS HAS REDUCED THE COMPANY’S OPERATING MARGIN IN THE SHORT TERM, BUT WILL LEAD TO HIGH GROWTH WITH HEALTHY MARGINS MOVING FORWARD.RAYSEARCH SAYS IN THE SECOND QUARTER, WE SAW SIGNS THAT OUR INVESTMENTS HAVE BEGUN TO YIELD RESULTS IN TERMS OF HIGHER ORDER INTAKE.RAYSEARCH SAYS NUMBER OF RADIATION THERAPY CENTERS WORLDWIDE IS EXPECTED TO GROW SHARPLY OVER NEXT DECADE, WE WILL CONTINUE TO GROW CONSIDERABLY FASTER THAN MARKET.  Full Article

Raysearch Says An Existing Client Extends Its Order
Thursday, 5 Jul 2018 

July 5 (Reuters) - RaySearch Laboratories AB (publ) ::COMPREHENSIVE CANCER CENTER AT WAKE FOREST BAPTIST HEALTH IN U.S. HAS PLACED ORDER FOR ADDITIONAL RAYSTATION TREATMENT PLANNING SYSTEMS.SYSTEMS OF THIS ORDER HAVE BEEN DELIVERED AND IS WILL GENERATE REVENUE IN Q1 OF 2018.  Full Article

Raysearch And Eckert & Ziegler Bebig Enter Into Partnership Regarding Brachytherapy
Tuesday, 3 Jul 2018 

July 3 (Reuters) - RAYSEARCH ::RAYSEARCH AND ECKERT & ZIEGLER BEBIG ENTER INTO PARTNERSHIP REGARDING BRACHYTHERAPY.  Full Article

Raysearch Says To Move Into New Geographic Markets In 2018
Wednesday, 9 May 2018 

May 9 (Reuters) - RaySearch Laboratories AB (publ) ::Q1 NET SALES SEK 116.3 M (126.8).Q1 OPERATING PROFIT SEK 14.1 M (33.5).Q1 ORDER INTAKE EXCLUDING. SERVICE AGREEMENTS SEK 106.6 M (104.9).HAS HAD POSITIVE START TO 2018 EVEN IF THIS CANNOT YET BE SEEN IN SALES FIGURE - CEO.EXPANSION PLANS MAY REDUCE OPERATING MARGIN IN SHORT TERM BUT WILL LEAD TO HIGH GROWTH WITH HEALTHY MARGINS IN THE FUTURE.IN 2018, WE WILL MOVE INTO NEW GEOGRAPHIC MARKETS AND HAVE STRONGER FOCUS ON SMALLER CLINICS AROUND THE WORLD.AIM TO HAVE AT LEAST 3,000 CLINICS THAT HAVE PURCHASED RAYSTATION WITHIN 10 YEARS, REPRESENTING A MARKET SHARE OF ABOUT 30 PERCENT.  Full Article

RaySearch Q3 operating profit falls to SEK 1 mln​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Raysearch Laboratories Ab (Publ) ::Q3 ‍operating profit sek 0.7 m (38.5).Q3 net sales SEK 111.7 M (125.7), of which revenues from RayStation SEK 99.1 M (112.6)​.Q3 ‍order intake excluding service agreements SEK 102.0 m (101.1)​.Raysearch says ‍at end of period, order backlog for RayStation was SEK 39.1 m (55.5)​.  Full Article

Raysearch warns of weaker than expected Q3
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Raysearch :Raysearch releases preliminary outcome for Q3 2017.Says ‍releases preliminary figures for Q3 of 2017, which appear to be weaker than expected​.Says ‍net sales for Q3 of 2017 are expected to amount to SEK 112 m (126) with operating profit of SEK 1 m (38) and cash flow of SEK -1 m (-4).Raysearch shares drop 12 pct after profit warning​.Says ‍result has been influenced by three main factors​:.‍Weak order intake in Europe, where several major public tenders have been delayed​.Continued weakening of the US dollar, where the company’s revenues have decreased as a consequence of a weaker US dollar, which also caused negative translation effects for balance sheet items.Increased costs, where the company so far this year, as a conscious effort, has increased the number of employees in the global market organization and in research and development by about 50 percent, which has not yet generated increased order intake.  Full Article